[go: up one dir, main page]

WO1997026016A3 - Gasblasensuspensionen und deren verwendung als ultraschallkontrastmittel - Google Patents

Gasblasensuspensionen und deren verwendung als ultraschallkontrastmittel Download PDF

Info

Publication number
WO1997026016A3
WO1997026016A3 PCT/EP1997/000208 EP9700208W WO9726016A3 WO 1997026016 A3 WO1997026016 A3 WO 1997026016A3 EP 9700208 W EP9700208 W EP 9700208W WO 9726016 A3 WO9726016 A3 WO 9726016A3
Authority
WO
WIPO (PCT)
Prior art keywords
application
gas bubble
contrast medium
ultrasound contrast
bubble suspensions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1997/000208
Other languages
English (en)
French (fr)
Other versions
WO1997026016A2 (de
Inventor
Martina Bergmann
Dieter Heldmann
Werner Weitschies
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Priority to JP9525697A priority Critical patent/JP2000504317A/ja
Priority to EP97902178A priority patent/EP0874644A2/de
Priority to AU15925/97A priority patent/AU1592597A/en
Publication of WO1997026016A2 publication Critical patent/WO1997026016A2/de
Publication of WO1997026016A3 publication Critical patent/WO1997026016A3/de
Priority to NO983332A priority patent/NO983332L/no
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
    • C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
    • C08J9/143—Halogen containing compounds
    • C08J9/147—Halogen containing compounds containing carbon and halogen atoms only
    • C08J9/148—Halogen containing compounds containing carbon and halogen atoms only perfluorinated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
    • C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
    • C08J9/143—Halogen containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2300/00—Characterised by the use of unspecified polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acoustics & Sound (AREA)
  • Physics & Mathematics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

Die Erfindung betrifft poröse Matrices aus niedermolekularen Substanzen zur Generierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zur Herstellung der Matrices und Mittel.
PCT/EP1997/000208 1996-01-18 1997-01-16 Gasblasensuspensionen und deren verwendung als ultraschallkontrastmittel Ceased WO1997026016A2 (de)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP9525697A JP2000504317A (ja) 1996-01-18 1997-01-16 気泡懸濁物と超音波造影剤への応用
EP97902178A EP0874644A2 (de) 1996-01-18 1997-01-16 Gasblasensuspensionen und deren verwendung als ultraschallkontrastmittel
AU15925/97A AU1592597A (en) 1996-01-18 1997-01-16 Gas bubble suspensions and their application as an ultrasound contrast medium
NO983332A NO983332L (no) 1996-01-18 1998-07-17 Gassboblesuspensjoner og deres anvendelse som ultralydkontrastmiddel

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602930.9 1996-01-18
DE19602930A DE19602930A1 (de) 1996-01-18 1996-01-18 Poröse Matrices aus niedermolekularen Substanzen zur Genierung stabiler Gasblasensuspensionen, deren Verwendung als Ultraschallkontrastmittel sowie Verfahren zu deren Herstellung

Publications (2)

Publication Number Publication Date
WO1997026016A2 WO1997026016A2 (de) 1997-07-24
WO1997026016A3 true WO1997026016A3 (de) 1997-10-23

Family

ID=7783852

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/000208 Ceased WO1997026016A2 (de) 1996-01-18 1997-01-16 Gasblasensuspensionen und deren verwendung als ultraschallkontrastmittel

Country Status (8)

Country Link
EP (1) EP0874644A2 (de)
JP (1) JP2000504317A (de)
AU (1) AU1592597A (de)
CA (1) CA2243174A1 (de)
DE (1) DE19602930A1 (de)
NO (1) NO983332L (de)
WO (1) WO1997026016A2 (de)
ZA (1) ZA97414B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT904113E (pt) 1996-03-05 2004-09-30 Acusphere Inc Gases fluorados microencapsulados para utilizacao como agentes de aquisicao de imagem
NZ592293A (en) * 2005-11-28 2012-10-26 Verrow Pharmaceuticals Inc Compositions comprising an oligosaccharide such as a cyclodextrin for reducing the nephrotoxicity of other drugs
JP5196896B2 (ja) * 2007-07-13 2013-05-15 花王株式会社 微細気泡前駆体の製造方法
JP2010005512A (ja) * 2008-06-25 2010-01-14 Kao Corp 微細気泡前駆体組成物
KR101927614B1 (ko) 2017-03-30 2018-12-10 숭실대학교산학협력단 초음파 영상을 위한 안정한 생체적합 산소-나노버블 조영제 제조방법
JP7211699B2 (ja) * 2017-09-11 2023-01-24 バイエル ファーマ アクチエンゲゼルシャフト 超音波診断用造影剤
US20240226418A1 (en) * 2021-01-26 2024-07-11 Agitated Solutions Inc. Syringe-Based Microbubble Generator

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122624A2 (de) * 1983-04-15 1984-10-24 Schering Aktiengesellschaft Mikropartikel und Gasbläschen enthaltendes Ultraschallkontrastmittel
EP0123235A2 (de) * 1983-04-15 1984-10-31 Schering Aktiengesellschaft Mikropartikel und Gasblächen enthaltendes Ultraschall-Kontrastmittel
EP0365467A2 (de) * 1988-10-07 1990-04-25 Schering Aktiengesellschaft Ultraschallkontrastmittel aus Gasbläschen und Fettsäure-enthaltenden Mikropartikeln
US5147631A (en) * 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
US5160725A (en) * 1987-03-24 1992-11-03 Silica Gel Gesellschaft Mbh Adsorptions-Technik, Apparatebau Magnetic liquid compositions
WO1992021382A1 (en) * 1991-06-03 1992-12-10 Holmes, Michael, John Improvements in or relating to contrast agents
WO1993000933A1 (en) * 1991-07-05 1993-01-21 University Of Rochester Ultrasmall non-aggregated porous particles entrapping gas-bubbles
WO1993013808A2 (en) * 1992-01-09 1993-07-22 Holmes, Michael, John Improvements in or relating to contrast agents
WO1995003835A1 (en) * 1993-07-30 1995-02-09 Alliance Pharmaceutical Corp. Stabilized microbubble compositions for ultrasound
WO1995021631A1 (en) * 1994-02-15 1995-08-17 Nycomed Imaging As Improvements in or relating to contrast agents
WO1996026746A1 (en) * 1995-02-28 1996-09-06 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3141641A1 (de) * 1981-10-16 1983-04-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Ultraschall-kontrastmittel und dessen herstellung
US5445813A (en) * 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
EP0593624B1 (de) * 1991-07-05 1997-04-23 Nycomed Imaging As Verbesserungen an kontrastmitteln
KR100191303B1 (ko) * 1991-09-17 1999-06-15 씨. 큐웨이 스티븐 기체상의 초음파 조영제 및 초음파 조영제로서 사용하기 위한 기체를 선택하는 방법
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
WO1995016467A1 (en) * 1993-12-15 1995-06-22 Bracco Research S.A. Gas mixtures useful as ultrasound contrast media
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0122624A2 (de) * 1983-04-15 1984-10-24 Schering Aktiengesellschaft Mikropartikel und Gasbläschen enthaltendes Ultraschallkontrastmittel
EP0123235A2 (de) * 1983-04-15 1984-10-31 Schering Aktiengesellschaft Mikropartikel und Gasblächen enthaltendes Ultraschall-Kontrastmittel
US5160725A (en) * 1987-03-24 1992-11-03 Silica Gel Gesellschaft Mbh Adsorptions-Technik, Apparatebau Magnetic liquid compositions
EP0365467A2 (de) * 1988-10-07 1990-04-25 Schering Aktiengesellschaft Ultraschallkontrastmittel aus Gasbläschen und Fettsäure-enthaltenden Mikropartikeln
US5147631A (en) * 1991-04-30 1992-09-15 Du Pont Merck Pharmaceutical Company Porous inorganic ultrasound contrast agents
WO1992021382A1 (en) * 1991-06-03 1992-12-10 Holmes, Michael, John Improvements in or relating to contrast agents
WO1993000933A1 (en) * 1991-07-05 1993-01-21 University Of Rochester Ultrasmall non-aggregated porous particles entrapping gas-bubbles
WO1993013808A2 (en) * 1992-01-09 1993-07-22 Holmes, Michael, John Improvements in or relating to contrast agents
WO1995003835A1 (en) * 1993-07-30 1995-02-09 Alliance Pharmaceutical Corp. Stabilized microbubble compositions for ultrasound
US5605673A (en) * 1993-07-30 1997-02-25 Alliance Pharmaceutical Corp. Stabilized microbubble compositions for ultrasound
WO1995021631A1 (en) * 1994-02-15 1995-08-17 Nycomed Imaging As Improvements in or relating to contrast agents
WO1996026746A1 (en) * 1995-02-28 1996-09-06 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement

Also Published As

Publication number Publication date
ZA97414B (en) 1997-07-17
NO983332D0 (no) 1998-07-17
JP2000504317A (ja) 2000-04-11
CA2243174A1 (en) 1997-07-24
DE19602930A1 (de) 1997-07-24
EP0874644A2 (de) 1998-11-04
AU1592597A (en) 1997-08-11
WO1997026016A2 (de) 1997-07-24
NO983332L (no) 1998-07-17

Similar Documents

Publication Publication Date Title
WO1996040077A3 (en) Methods for stably incorporating substances within dry, foamed glass matrices and compositions obtained thereby
CA2258502A1 (en) Modified factor viii
AU1374797A (en) Adsorbent for phosphate from an aqueous medium, production and use of said adsorbent
CA2226221A1 (en) Cell-free synthesis of polyketides
AU6687396A (en) Strong, air permeable membranes of polytetrafluoroethylene
AU1269399A (en) Printing medium comprised of porous medium
CA2224491A1 (en) A highly purified biogenic silica product
WO2000040525A3 (en) Polymer arrays and methods of making and using same
CA2232242A1 (en) Long wavelength engineered fluorescent proteins
CA2069759A1 (en) Liposomes as contrast agents for ultrasonic imaging
WO1997026270A3 (en) Synthesis of methoxy nucleosides and enzymatic nucleic acid molecules
WO1997032607A3 (en) Activated linkers and methods for making and purifying the same
AU1091899A (en) Methods of making a molecular sieve containing catalyst
BG100571A (en) Toothpaste having lowering leaking characteristics andimproved flavour, containing silicon dioxide abrasive
IL143670A0 (en) Methods for the expression of active protein-immunoglobulin fusions, active protein-immunoglobulin fusions obtained thereby and pharmaceutical compositions containing the same
AU3108099A (en) Membrane process for producing carbon dioxide
GC0000119A (en) Improved chromate ester catalyst and method of using same to produce high performance polyethylene products.
WO1997026016A3 (de) Gasblasensuspensionen und deren verwendung als ultraschallkontrastmittel
WO1996039512A3 (en) A cell line for the rapid expression of functional calcium channels
GR1002616B (el) Συνθεση και μεθοδος συνθεσης μοριου: τετραυδρο-ν,ν-διμεθυλο-2,2-διφαινυλο-3-φουρανομεθαναμινης (αε 37), αντισπασμωδικης, αντικαταθλιπτικης και νοοτροπικης δρασης.
EP2011503A3 (de) Hochaffine Nukleinsäureliganden für Zytokine
AU4853297A (en) Container formed from copolyester composition, copolyester composition therefor and method of producing the same
DE69233634D1 (de) Gasplasma behandeltes, poröses Medium und Trennungsmethode unter Verwendung des Mediums
ZA972627B (en) Process for the preparation of an intermediate useful in the synthesis of iodinated contrast media.
WO2002024343A3 (de) Verfahren zur herstellung einer beschichtung auf porösen und/oder saugfähigen materialien

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AU AZ BB BG BR BY CA CN CZ EE GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LV MD MG MK MN MW MX NO NZ PL RO RU SD SG SI SK TJ TM TR TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1997902178

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2243174

Country of ref document: CA

Ref country code: CA

Ref document number: 2243174

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1997902178

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997902178

Country of ref document: EP